United States Market for In Vitro Diagnostic (IVD) Tests

    Published: June 7, 2021 | Price: $4,000 – $8,000

    The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...
    At-Home Testing: COVID-19 Trends and Future Potential

    Published: April 15, 2021 | Price: $3,000 – $6,000

    This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...
    Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)

    Published: April 12, 2021 | Price: $4,000 – $8,000

    Contract manufacturing is an increasing part of the pharmaceutical business.  In cell therapy this need is magnified because of the demand for cell and gene therapy products.  Kalorama Information's report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, Key Players, and Competitors in the Market COVID-19’s Challenges and Opportunities for CMOs Global and Regional Market Overviews—U.S., Europe, and Other Nations New Developments and...
    2021 IVD Market Update and COVID-19 Impact

    Published: March 12, 2021 | Price: $3,000 – $6,000

    What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...
    Vaccines 2020: World Market Analysis, Players, Trends

    Published: November 4, 2020 | Price: $4,000 – $8,000

    Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION  The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...
    COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

    Published: November 2, 2020 | Price: $4,000 – $8,000

    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...
    Sepsis Diagnostics Products and Market Trends

    Published: October 26, 2020 | Price: $3,000 – $6,000

    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...
    Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets

    Published: May 14, 2020 | Price: $4,000 – $8,000

    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...
    Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas

    Published: April 7, 2020 | Price: $750 – $1,000

    For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...